Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan · Delayed Price · Currency is TWD 116.50
+1.50 (1.30%)
At close: Jul 9, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 6.1 billion as of July 9, 2026. Its market cap has increased by 91.80% in one year.
Market Cap
6.10B
Enterprise Value
5.76B
Revenue
5.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
116.50
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 6.10B, an increase of 191.93%. That is a compound annual growth rate of 9.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 6.10B | 6.48% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 16.47B |
| Pharmasaga | 12.80B |
| TEH SENG Pharmaceutical Mfg. | 2.36B |
| Libo Pharma | 2.26B |
| Anbogen Therapeutics | 1.98B |
| Timing Pharmaceutial | 1.73B |
| Anya Biopharm | 1.67B |
| TSA International | 1.61B |